FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1255588004: Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5147719012 Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5158352012 Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

22 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Is a Neoplasm observable true Inferred relationship Some
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inheres in Malignant neoplasm (morphologic abnormality) true Inferred relationship Some 4
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Property (attribute) Presence (property) (qualifier value) true Inferred relationship Some 1
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Scale type (attribute) Ordinal value true Inferred relationship Some 2
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Characterizes (attribute) Malignant proliferation of primary neoplasm (qualifier value) true Inferred relationship Some 5
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Characterizes (attribute) Regression of neoplasm (qualifier value) true Inferred relationship Some 6
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Precondition (attribute) Neoadjuvant antineoplastic therapy (procedure) true Inferred relationship Some 7
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Time aspect (attribute) Single point in time true Inferred relationship Some 3
Inbound Relationships Type Active Source Characteristic Refinability Group
Presence of regression of primary malignant neoplasm of esophagus after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of anus after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of pancreas after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of liver after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of prostate after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of stomach after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of fallopian tube after neoadjuvant antineoplastic therapy (observable entity) Is a False Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of ovary after neoadjuvant antineoplastic therapy (observable entity) Is a False Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of lung after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of breast after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of thymus after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of soft tissue after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of bone after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of colon after neoadjuvant antineoplastic therapy (observable entity) Is a False Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of central nervous system after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant mesothelioma after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of uterine adnexa after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of pleural membrane after neoadjuvant antineoplastic therapy (observable entity) Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of primary malignant neoplasm of caecum and/or colon and/or rectum after neoadjuvant antineoplastic therapy Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some
Presence of regression of Ewing's sarcoma after neoadjuvant antineoplastic therapy Is a True Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) Inferred relationship Some

This concept is not in any reference sets

Back to Start